We have placed cookies on your device to improve this website. You can change your cookie settings at any time and receive further information regarding cookies . Otherwise, we will assume you're OK to continue.
You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
Kedrion Portugal is a biopharmaceutical company specializing in marketing, sales and distribution of plasma derivatives in Portugal. Kedrion Portugal was founded in 2010 and is based in Lisbon, Portugal, where we service the hospital pharmaceutical market of Portugal. We are a wholly-owned subsidiary of Kedrion International GmbH, based in Vienna, Austria. In turn, Kedrion International GmbH is a wholly owned subsidiary of Kedrion S.p.A., based in Castelvecchio, Italy. Kedrion Portugal distributes Kedrion products exclusively in Portugal.
Kedrion Portugal provides plasma-derived therapies for:
- Immune system diseases
- Illnesses and conditions that require critical care, and
- Bleeding disorders.
Human Normal Immunoglobulins
Human Hyperimmune Immunoglobulins
Human Albumin Solutions
Albumina Humana Kedrion
These high-safety therapies are produced by Kedrion S.p.A. from human plasma collected only in Europe and the USA.